CSHNX
Price
$12.51
Change
+$0.06 (+0.48%)
Updated
Jan 17 closing price
Net Assets
1.17B
HMSFX
Price
$13.83
Change
+$0.04 (+0.29%)
Updated
Jan 17 closing price
Net Assets
85.1M
Ad is loading...

CSHNX vs HMSFX

Header iconCSHNX vs HMSFX Comparison
Open Charts CSHNX vs HMSFXBanner chart's image
NYLI Cushing® MLP Premier Investor Class
Price$12.51
Change+$0.06 (+0.48%)
VolumeN/A
Net Assets1.17B
Hennessy Midstream Investor
Price$13.83
Change+$0.04 (+0.29%)
VolumeN/A
Net Assets85.1M
CSHNX vs HMSFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSHNX vs. HMSFX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and HMSFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSHNX has more cash in the bank: 1.17B vs. HMSFX (85.1M). HMSFX pays higher dividends than CSHNX: HMSFX (9.01) vs CSHNX (7.86). CSHNX was incepted earlier than HMSFX: CSHNX (11 years) vs HMSFX (11 years). CSHNX is a more actively managed with annual turnover of: 20.00 vs. HMSFX (16.00). CSHNX (2500) and HMSFX (2500) have matching initial minimum investment requirements. CSHNX annual gain was more profitable for investors over the last year : 57.33 vs. HMSFX (48.47). HMSFX return over 5 years is better than : 113.81 vs. CSHNX (85.63).
CSHNXHMSFXCSHNX / HMSFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years11 years-
Gain YTD9.5458.754109%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B85.1M1,371%
Annual Yield % from dividends7.869.0187%
Returns for 1 year57.3348.47118%
Returns for 3 years104.90114.1092%
Returns for 5 years85.63113.8175%
Returns for 10 years34.4659.6158%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR19.560.54
+2.84%
Arrowhead Pharmaceuticals
AXR32.780.51
+1.58%
AMREP Corp
SNN25.290.24
+0.96%
Smith & Nephew plc
CTLP8.150.04
+0.49%
Cantaloupe
VRPX0.30-0.01
-2.06%
Virpax Pharmaceuticals